Kikuchi S, Negoro E, Horaguchi R, Fujihira T, Nabe Y, Minemura T, Ono K, Kamihara Y, Wada A, Dang NH, Masaki Y, Miyamoto T, Yamauchi T, Sato T. Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial). haematol [Internet]. 2020Sep.10 [cited 2026May9];. Available from: https://haematologica.org/article/view/14164